The co-founder and former CEO of Canopy Growth has a lot to say about his new SPAC, how the election will change the cannabis industry, and electric vehicles.
News & Analysis: GW Pharmaceuticals
These cannabis stocks are ready to show investors the green.
The stock has fallen more than 20% in just the past three months.
Investors will want to preserve their hard-earned capital by staying away from these marijuana companies for now.
Both have struggled over the past year, but there are reasons to expect their stocks could stage strong comebacks over the longer term.
In a complicated legal landscape, one FDA-approved cannabis product can help investors pick the winner.
Shares of the only producer of FDA-approved CBD have tumbled this summer.
The green rush was in full force for some top-notch money managers in the second quarter.
Here's why these recession-proof stocks are great buy-and-hold opportunities for the long term.
A new Canadian study could have ramifications for the entire marijuana industry.